Recent Developments: 2025: Eli Lilly received FDA approval for tirzepatide (Zepbound) as a treatment for moderate-to-severe obstructive sleep apnea in adults with obesity the first pharmacotherapy approved for this indication expanding tirzepatide's approved uses beyond metabolic conditions into a respiratory indication affecting over 30 million Americans and supported by SURMOUNT-OSA trial data showing 63% reduction in apnea-hypopnea index
Accuracy matters more than most people realize, which is why resources like the peptide calculator exist to help with these calculations
ongoing monitoring labs, typically quarterly
That being said, he adds, we are open to exploring foodservice options in the future as additional pathways to introduce consumers to Supergut by encouraging trial and hopefully motivating them to come back and purchase our products from our website, Amazon storefront, or from one of our retail partners.
Zhang C, Zhang F
LDN is generally taken before bedtime, unless it causes sleep disturbance, in which case it can be taken in the morning